Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Similar articles for PubMed (Select 15258334)

1.

Novel approaches to visualization and data mining reveals diagnostic information in the low amplitude region of serum mass spectra from ovarian cancer patients.

Johann DJ Jr, McGuigan MD, Tomov S, Fusaro VA, Ross S, Conrads TP, Veenstra TD, Fishman DA, Whiteley GR, Petricoin EF, Liotta LA.

Dis Markers. 2003-2004;19(4-5):197-207.

2.

High-resolution serum proteomic features for ovarian cancer detection.

Conrads TP, Fusaro VA, Ross S, Johann D, Rajapakse V, Hitt BA, Steinberg SM, Kohn EC, Fishman DA, Whitely G, Barrett JC, Liotta LA, Petricoin EF 3rd, Veenstra TD.

Endocr Relat Cancer. 2004 Jun;11(2):163-78.

3.

Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer.

Kong F, Nicole White C, Xiao X, Feng Y, Xu C, He D, Zhang Z, Yu Y.

Gynecol Oncol. 2006 Feb;100(2):247-53. Epub 2005 Oct 17.

PMID:
16229881
4.

[Identification of serum biomarkers for ovarian cancer using protein chips and time of flight mass spectrometry technology].

Wang Q, Li L, Li DR, Zhang W, Wei X, Zhang JQ, Tang Y.

Zhonghua Fu Chan Ke Za Zhi. 2006 Aug;41(8):544-8. Chinese.

PMID:
17083841
5.
6.

Proteomic studies of early-stage and advanced ovarian cancer patients.

Wang J, Zhang X, Ge X, Guo H, Xiong G, Zhu Y.

Gynecol Oncol. 2008 Oct;111(1):111-9. doi: 10.1016/j.ygyno.2008.06.031. Epub 2008 Aug 15.

PMID:
18703221
7.

Biomarker discovery for ovarian cancer using SELDI-TOF-MS.

Zhang H, Kong B, Qu X, Jia L, Deng B, Yang Q.

Gynecol Oncol. 2006 Jul;102(1):61-6. Epub 2006 Jan 5.

PMID:
16403569
8.

Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.

Callesen AK, Christensen Rd, Madsen JS, Vach W, Zapico E, Cold S, Jørgensen PE, Mogensen O, Kruse TA, Jensen ON.

Rapid Commun Mass Spectrom. 2008;22(3):291-300. doi: 10.1002/rcm.3364.

PMID:
18181248
9.

Plasma proteomic pattern as biomarkers for ovarian cancer.

Lin YW, Lin CY, Lai HC, Chiou JY, Chang CC, Yu MH, Chu TY.

Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:139-46.

PMID:
16515582
10.

Proteomic patterns for classification of ovarian cancer and CTCL serum samples utilizing peak pairs indicative of post-translational modifications.

Liu C, Shea N, Rucker S, Harvey L, Russo P, Saul R, Lopez MF, Mikulskis A, Kuzdzal S, Golenko E, Fishman D, Vonderheid E, Booher S, Cowen EW, Hwang ST, Whiteley GR.

Proteomics. 2007 Nov;7(22):4045-52.

PMID:
17952875
11.

Diagnostic potential of serum proteomic patterns in prostate cancer.

Bañez LL, Prasanna P, Sun L, Ali A, Zou Z, Adam BL, McLeod DG, Moul JW, Srivastava S.

J Urol. 2003 Aug;170(2 Pt 1):442-6.

PMID:
12853795
12.
13.

Methods for visual mining of genomic and proteomic data atlases.

Boyle J, Kreisberg R, Bressler R, Killcoyne S.

BMC Bioinformatics. 2012 Apr 23;13:58. doi: 10.1186/1471-2105-13-58.

14.

Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.

Lu HB, Zhou JH, Ma YY, Lu HL, Tang YL, Zhang QY, Zhao CH.

Jpn J Clin Oncol. 2010 Apr;40(4):336-42. doi: 10.1093/jjco/hyp175. Epub 2010 Jan 20.

15.

Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.

Pietrowska M, Marczak L, Polanska J, Behrendt K, Nowicka E, Walaszczyk A, Chmura A, Deja R, Stobiecki M, Polanski A, Tarnawski R, Widlak P.

J Transl Med. 2009 Jul 13;7:60. doi: 10.1186/1479-5876-7-60.

16.

Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.

Brozkova K, Budinska E, Bouchal P, Hernychova L, Knoflickova D, Valik D, Vyzula R, Vojtesek B, Nenutil R.

Breast Cancer Res. 2008;10(3):R48. doi: 10.1186/bcr2101. Epub 2008 May 29.

17.

Serum peptide/protein profiling by mass spectrometry provides diagnostic information independently of CA125 in women with an ovarian tumor.

Callesen AK, Madsen JS, Iachina M, Vach W, Kruse TA, Jensen ON, Mogensen O.

Cancer Biomark. 2010;6(2):73-82. doi: 10.3233/CBM-2009-0120.

PMID:
20571233
18.

On the analysis of glycomics mass spectrometry data via the regularized area under the ROC curve.

Ye J, Liu H, Kirmiz C, Lebrilla CB, Rocke DM.

BMC Bioinformatics. 2007 Dec 12;8:477.

19.

A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples.

Lopez MF, Mikulskis A, Kuzdzal S, Golenko E, Petricoin EF 3rd, Liotta LA, Patton WF, Whiteley GR, Rosenblatt K, Gurnani P, Nandi A, Neill S, Cullen S, O'Gorman M, Sarracino D, Lynch C, Johnson A, Mckenzie W, Fishman D.

Clin Chem. 2007 Jun;53(6):1067-74. Epub 2007 Apr 26.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk